AARC Opposition Statement On the FDA’s Authorization of Juul E-Cigarette Products:

Respiratory therapists are dedicated to treating patients with chronic respiratory diseases, many of which are directly linked to tobacco and nicotine use. Respiratory therapists see firsthand the long-term consequences of addiction that often begin in adolescence. The decision to allow these products on the market contradicts the FDA’s mission to protect public health and will make it harder for families and health professionals to reverse course on youth vaping.